Checkmate Pharmaceuticals, Inc.: key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2021)
- -$61.4M
- Total Assets (FY2021)
- $78.8M
- Total Equity (FY2021)
- $69.5M
- Cash Flows from Operating Activities (FY2021)
- -$53.7M
Source: Checkmate Pharmaceuticals, Inc. 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
